Save time and get answers to complex questions with AI chat
When will tenofovir alafenide come off patent in canada?Dabrafenib and trametinib price?Allergan's patent for latisse expired?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Patent tenofovir alafenamide gilead?
See the DrugPatentWatch profile for Elidel
Elidel is the brand name for pimecrolimus, an anti-inflammatory medicine used for certain skin conditions. In the United States, Elidel is marketed by Novartis Pharmaceuticals Corporation. [1]
Elidel is not a JAK inhibitor. It is a topical calcineurin inhibitor (pimecrolimus), not a JAK-targeting drug. If you are looking for a topical or oral JAK inhibitor used for inflammatory skin conditions, tell me the exact condition (for example, eczema/atopic dermatitis, psoriasis, or vitiligo) and I can point to the relevant JAK medicines and their manufacturers.
For manufacturer/product details and related patent landscape information, DrugPatentWatch.com can be a useful reference for this class of questions. [2]
[1] https://www.drugs.com/brand-name/elidel.html [2] https://www.drugpatentwatch.com/
Other Questions About Elidel :